CME vs MA: Which Is the Better Dividend Stock?
As of Nov 5, 2026, CME and MA are closely matched. CME offers the higher yield at 1.69%, CME has the higher dividend-safety score, and MA looks like the better value (its fair-value estimate is 25% below its share price).
Key facts: CME vs MA
Data as of · Source: SmarterDividends data
- As of Nov 5, 2026, CME Group Inc. (CME) has the higher forward dividend yield at 1.69%, versus 0.52% for Mastercard Incorporated (MA).
- As of Nov 5, 2026, SmarterDividends grades CME's dividend safety A (90/100) and MA's A (89/100).
- By SmarterDividends' count as of Nov 5, 2026, CME has raised its dividend for 15 consecutive years and MA for 14.
- As of Nov 5, 2026, CME pays out 93% of its earnings as dividends and MA pays out 18%.
- As of Nov 5, 2026, CME's fair-value estimate is 37% below its share price and MA's fair-value estimate is 25% below its share price, so MA looks like the better value of the two on SmarterDividends' blended model.
Cite this page
SmarterDividends, "CME vs MA: Dividend Yield, Safety & Value Compared," updated Nov 5, 2026, https://smarterdividends.com/compare/cme-vs-ma
| Metric | CME | MA |
|---|---|---|
| Forward yield | 1.69% | 0.52% |
| Annual dividend | $5.20 | $3.48 |
| Payout ratio | 93% | 18% |
| Years of growth | 15 yr | 14 yr |
| 5-yr dividend growth | 8.0% | 13.7% |
| 5-yr total return | 37% | 103% |
| Dividend safety score | 90 (A) | 89 (A) |
| Fair value estimate | $193.87 | $499.25 |
| Upside to fair value | -37% | -25% |
| Frequency | quarterly | quarterly |
| Market cap | $110.0B | $578.5B |
| P/E ratio | 25.2 | 34.7 |
Higher yield
CME
1.69%
Safer dividend
CME
Grade A
Faster growth
MA
13.7%
Better value
MA
-25% upside
CME vs MA — FAQ
Is CME or MA a better dividend stock?
CME and MA are closely matched. CME has the higher yield; CME scores better on safety.
Which has a higher dividend yield, CME or MA?
CME has the higher forward dividend yield at 1.69%, versus 0.52% for MA.
Is CME or MA safer?
CME has the higher dividend-safety score (90/100 vs 89/100), reflecting stronger payout coverage and dividend-growth history.
Is CME or MA better value right now?
As of Nov 5, 2026, MA looks like the better value: its fair-value estimate is 25% below its share price (overvalued). For CME, its fair-value estimate is 37% below its share price.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.